Prospect Capital Reports December 2016 Quarterly Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
102
Prospect Capital Reports December 2016 Quarterly Results

NEW YORK , Feb. 08, 2017 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC ) (“Prospect”, “our”, or “we”) today announced financial results for our second fiscal quarter ended December 31, 2016.

All amounts in $000’s except   per share amounts Quarter Ended  December 31, 2016  Quarter Ended  September 30, 2016  Quarter Ended  December 31, 2015 
       
Net Investment Income (“NII”)   $84,405 $78,919 $100,893
NII per Share $0.24 $0.22 $0.28
       
Net Income (“NI”) $100,880 $81,366 $(95,120)
NI per Share $0.28 $0.23 $(0.27)
       
Distributions to Shareholders $89,668 $89,428 $88,827
Distributions per Share $0.25 $0.25 $0.25
       
NAV per Share at Period End $9.62 $9.60 $9.65
       
Debt to Equity Ratio 76.2% 77.4% 80.2%
       

For the December 2016 quarter, we earned net investment income ("NII") of $84.4 million, or $0.24 per weighted average share, up $0.02 per share from the September 2016 quarter, primarily from an increase in interest and other income from new investments made during the September and December 2016 quarters and a decrease in operating expenses partially due to a reversal of excise tax previously accrued.

For the December 2016 quarter, our net income (“NI”) was $100.9 million or $0.28 per weighted average share, an increase of $0.05 per share from $81.4 million, or $0.23 per weighted average share, in the September 2016 quarter, primarily due to unrealized appreciation on our investments. For the December 2015 quarter, our NI was $(95.1) million or $(0.27) per weighted average share. NI increased year-over-year in the December 2016 quarter primarily due to a favorable decrease in unrealized losses that occurred primarily due to volatility in the capital markets in the December 2015 quarter.

All amounts in $000’s except   per share amounts Six Months Ended  December 31, 2016  Six Months Ended  December 31, 2015 
     
Net Investment Income (“NII”)   $163,324 $192,135
NII per Share $0.46 $0.54
     
Net Income (“NI”) $182,246 $(67,303)
NI per Share $0.51 $(0.19)
     
Distributions to Shareholders $179,097 $177,942
Distributions per Share $0.50 $0.50
         

For the six months ended December 31, 2016, we earned NII of $163.3 million, or $0.46 per weighted average share. For the six months ended December 31, 2015, our NII was $192.1 million, or $0.54 per weighted average share. NII decreased by $28.8 million, or $0.08 per weighted average share, year-over-year primarily as a result of a decrease in non-recurring dividend income from NPRC, a decrease in interest income from energy-related loans, and a reduced interest earning asset base. These income declines were partially offset by a decrease in advisory fees.

For the six months ended December 31, 2016, our NI was $182.2 million, or $0.51 per weighted average share. For the six months ended December 31, 2015, our NI was $(67.3) million, or $(0.19) per weighted average share. NI increased by $249.5 million, or $0.70 per weighted average share, year-over-year primarily due to unrealized appreciation of our investments.

With the Harbortouch sale and other significant repayments, we were underinvested during the first half of fiscal 2017, carrying an average cash balance of $167.7 million. If we had booked another $460 million of 10% annualized coupon earning assets July 1, 2016, utilizing our uninvested cash and financing the remainder (approximately $300 million) from our revolving credit facility, our fiscal year to date NII would have increased by $14.5 million, before any structuring fee income earned in connection with such originations.

As of December 31, 2016, our reported net asset value (“NAV”) per share was $9.62, up $0.02 from September 30, 2016.

Our debt to equity ratio was 76.2% at December 31, 2016, down 400 bps from 80.2% at December 2015. Our balance sheet as of December 31, 2016 comprised 90.4% floating rate interest earning assets and 99.9% fixed rate liabilities, positioning us to benefit from potential increases in short-term interest rates.

Our recurring income as measured by our percentage of total investment income from interest income was 95% in the December 2016 quarter.

PORTFOLIO AND INVESTMENT ACTIVITY

We continue to prioritize secured lending. As of December 31, 2016, our portfolio at fair value consisted of 45.9% first lien, 23.6% second lien, 18.3% structured credit (with underlying first lien), 11.2% equity investments, 0.8% unsecured debt, and 0.2% small business whole loan. As of December 31, 2016, our control investments at fair value were 31.5% of our portfolio.

Our portfolio’s annualized current yield stood at 13.2% across all performing interest bearing investments as of December 31, 2016, up 0.4% from 12.8% as of September 30, 2016.

At December 31, 2016, our portfolio consisted of 123 long-term investments with a fair value of $5.937 billion, spanning a diversified range of industries with no one industry (excluding our underlying industry-diversified structured credit portfolio) representing more than 9.3% of the portfolio at fair value, and energy representing 2.6%. The fair value of our loans on non-accrual as a percentage of total assets was approximately 1.5% at December 31, 2016, with 0.4% in the energy industry. For a listing of transactions completed during the quarter, please see the section titled “Portfolio Investment Activity” in our form 10-Q for the quarter ended December 31, 2016.

As of December 31, 2016, our weighted average portfolio net leverage stood at 4.77 times earnings before interest, taxes, depreciation, and amortization (“EBITDA”). As of December 31, 2016, our weighted average EBITDA per portfolio company was $51.6 million.

During the December 2016 quarter, we completed new and follow-on investments aggregating $469.5 million and received full repayments on nine investments. Our sales, repayments, and scheduled amortization payments in the December 2016 quarter were $645.0 million, resulting in net repayments of $175.5 million.

During the December 2016 quarter, our originations comprised 54% syndicated debt (including early look anchoring investments and club investments), 15% third party sponsor deals, 15% online lending, 7% structured credit, 4% aircraft leasing, 3% real estate, and 2% operating buyouts.

In addition to a substantial investment in real estate, we and NPRC continued our investment in the online lending industry with a focus on super-prime, prime, and near-prime consumer and small business borrowers. We and NPRC currently have exposure to $846.6 million of loans directly and through securitization interests, across multiple origination and underwriting platforms. Our online business is currently delivering a yield on our invested capital exceeding 14% (net of all incurred costs and expected losses). NPRC currently has five bank credit facilities supporting its online business, and an NPRC subsidiary closed a consumer securitization during the December 2016 quarter.

As of December 31, 2016 we were invested in 41 structured credit investments with a fair value of $1.09 billion with individual standalone financings non-recourse to Prospect and with our risk capped at our net investment amount. The underlying structured credit portfolios comprise over 2,800 loans and a total asset base of over $20.0 billion. As of December 31, 2016, our structured credit portfolio experienced a trailing twelve month default rate of 1.16%, or 42 basis points less than the broadly syndicated market trailing twelve month default rate of 1.58%. In the December 2016 quarter, our structured credit equity portfolio generated an annualized cash yield of 21.5% and an annualized GAAP yield of 14.8% based on December 31, 2016 fair value. As of December 31, 2016, our existing structured credit portfolio has generated $812.9 million in cumulative cash distributions to us, representing 61.9% of our original investment. In addition, we have exited seven structured credit investments totaling $153.6 million with an average realized IRR of 16.8% and cash on cash multiple of 1.42 times.

Prospect’s structured credit portfolio has paid to Prospect an average 24.4% cash yield (based on December 2016 fair value) in the twelve months ended December 31, 2016. Since August 29, 2016 (the date of our June 2016 earnings release), five of our structured credit investments completed refinancings to reduce the cost of liabilities (three of which occurred after December 2016) and three additional structured credit investments completed multi-year extensions of the reinvestment period of such investments. We are working on identifying for our independent management teams further structured credit investment refinancings and extensions in the portfolio to enhance value.

To date during the March 2017 quarter, we have completed new and follow-on investments of $273.1 million, and received repayments of $26.3 million, resulting in net investments of $246.8 million. Our originations in the March 2017 quarter have comprised 66% third party sponsor deals, 15% real estate, 8% online lending, 6% operating buyout, and 5% syndicated debt.

LIQUIDITY AND FINANCIAL RESULTS

Our debt to equity ratio was 76.2% at December 31, 2016. We repaid our $167.5 million August 2016 convertible note issue at maturity. For the remainder of fiscal year 2017, our liability maturities do not exceed $5 million.

On August 29, 2014, we renegotiated and closed an expanded five and a half year revolving credit facility (the “Facility”). The Facility lenders have extended commitments of $885.0 million under the Facility as of December 31, 2016. The Facility includes an accordion feature which allows commitments to be increased to $1.5 billion in the aggregate. On August 22, 2016, the 2014 Facility was amended to eliminate some of the restrictions in the definition of an eligible loan for pledging to the facility and increase our overall borrowing base. Interest on borrowings under the Facility is one-month LIBOR plus 225 basis points, with no minimum LIBOR floor. The Facility continues to carry an investment-grade Moody’s rating of Aa3.

We have diversified our counterparty risk. As of December 31, 2016, 21 institutional lenders committed to the Facility compared to five lenders at June 30, 2010, one of the most diversified bank groups in our industry. The revolving period of the Facility extends through March 2019, with an additional one-year amortization period to March 2020, with distributions allowed after the completion of the revolving period. We currently have no borrowing drawn under our Facility.

We have seven separate unsecured debt issuances aggregating $1.7 billion outstanding, not including our program notes, with maturities ranging from October 15, 2017 to June 15, 2024. As of December 31, 2016, $962.1 million of program notes were outstanding with staggered maturities through October 2043.

As of December 31, 2016, we held approximately $4.8 billion of unencumbered assets on our balance sheet, representing approximately 77.8% of our total assets.

TAXABLE INCOME

All amounts in $000’s except   per share amounts Quarter Ended  December 31, 2016  Quarter Ended  September 30, 2016  Quarter Ended  December 31, 2015 
       
Estimated Distributable Income (“DI”)* $73,344 $73,151 $88,804
Estimated DI per Share* $0.20 $0.20 $0.25
       
Estimate of Amount Available for Spillback (“Spillback”)*   $34,392 $50,637 $93,071
Estimated Spillback per Share* $0.10 $0.14 $0.26
             

* We have adjusted DI and Spillback for prior periods to reflect updated structured credit tax results. DI is estimated to have decreased by $3.8 million and $12.1 million for the quarters ended September 30, 2016 and December 31, 2015, respectively. Spillback is estimated to have decreased by $46.0 million and $15.5 million as of September 30, 2016 and December 31, 2015, respectively.

All amounts in $000’s except   per share amounts Six Months Ended  December 31, 2016  Six Months Ended  December 31, 2015 
     
Estimated Distributable Income (“DI”)*   $146,495 $184,839
Estimated DI per Share* $0.41 $0.52
         

* We have adjusted DI to reflect updated structured credit tax reporting data. DI is estimated to have decreased by $3.8 million and $15.5 million for the six months ended December 31, 2016 and December 31, 2015, respectively.

As a tax-efficient regulated investment company, our 90% minimum shareholder dividend payout requirement is based on taxable income (“distributable income” or “DI”) rather than GAAP NII. DI occasionally decouples from NII. For the December 2016 quarter, our distributable income was $73.3 million or $0.20 per weighted average share, unchanged from $0.20 per weighted average share in the September 2016 quarter and down $0.05 per weighted average share from the December 2015 quarter. The decrease from the December 2015 quarter was due to a decline in taxable income from structured credit investments.

Regulated investment companies may utilize dividends from the subsequent tax year to increase the amount of taxable distributions to match taxable income for the prior year. As of December 31, 2016, we estimate that we have available to us $34.4 million, or $0.10 per weighted average share, in spillback dividends.

In the prior quarter, we estimated that our available spillback income was $96.6 million, $62.2 million more than the $34.4 million reported this quarter. Realized gains and losses on underlying individual loans in our structured credit investments are reported as taxable events when calculating our taxable income, and losses on sales of such assets reduce our taxable income. Many of the taxable differences from GAAP income are not reported until the final tax returns for the structured credit investments are issued.  Such tax returns can be delayed as long as nine months after the tax year end of the structured credit investment. During portions of calendar years 2015 and 2016, the broadly syndicated loan market sold off significantly, and the independent management teams of most of our structured credit investments took advantage of the volatility in the loan market to both sell certain loans and purchase new loans at discounted prices. While the sales and purchases of such loans at similarly discounted prices did not have an economic impact on our NII for financial statement purposes, the sales at discounted prices resulted in immediate harvesting of taxable losses, but corresponding purchases at discounted prices do not generate immediate taxable gains. We expect the underlying loans purchased at a discount in our structured credit investments will generate taxable income in the future as such loans amortize to par over the holding period (with taxable income acceleration if loans are sold or refinanced at a profit before maturity), reversing prior recent negative taxable income into positive future taxable income in our structured credit investments.  Taxable income is subject to revision as additional information is received and is subject to change.

EARNINGS CONFERENCE CALL

Prospect will host an earnings conference call on Thursday, February 9, 2017 , at 11:00 am. Eastern Time. The conference call dial-in number will be 888-338-7333 . A recording of the conference call will be available for approximately 30 days. To hear a replay, call 877-344-7529 and use passcode 10100513. The updated Prospect corporate presentation is available on the Investor Relations tab at www.prospectstreet.com . For copies of our corporate presentation, our recent shareholder letter, and our performance data please see http://shareholder.prospectstreet.com .

The conference call will also be available via a live listen-only webcast on Prospect’s website, www.prospectstreet.com . Please allow extra time prior to the call to visit the site and download any necessary software that may be needed to listen to the Internet broadcast. A replay of the audio webcast will be available on Prospect’s website for approximately 30 days following the conference call.

 
PROSPECT CAPITAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share and per share data)
   December 31, 2016   June 30, 2016
   
  (Unaudited)   (Audited)
Assets      
Investments at fair value:      
Control investments (amortized cost of $1,880,883 and $1,768,220, respectively) $ 1,867,410     $ 1,752,449  
Affiliate investments (amortized cost of $8,530 and $10,758, respectively) 7,819     11,320  
Non-control/non-affiliate investments (amortized cost of $4,222,503 and $4,312,122, respectively) 4,061,770     4,133,939  
Total investments at fair value (amortized cost of $6,111,916 and $6,091,100, respectively) 5,936,999     5,897,708  
Cash 203,911     317,798  
Receivables for:      
Interest, net 23,943     12,127  
Other 6,484     168  
Prepaid expenses 670     855  
Deferred financing costs on Revolving Credit Facility 6,141     7,525  
Total Assets 6,178,148     6,236,181  
       
Liabilities      
Revolving Credit Facility      
Prospect Capital InterNotes® 947,172     893,210  
Convertible Notes 909,505     1,074,361  
Public Notes 737,311     699,368  
Due to Prospect Capital Management 52,212     54,149  
Interest payable 38,419     40,804  
Dividends payable 29,915     29,758  
Due to Prospect Administration 3,010     1,765  
Accrued expenses 2,885     2,259  
Other liabilities 3,123     3,633  
Due to broker     957  
Total Liabilities 2,723,552     2,800,264  
Commitments and Contingencies      
Net Assets $ 3,454,596     $ 3,435,917  
       
Components of Net Assets      
Common stock, par value $0.001 per share (1,000,000,000 common shares authorized; 359,000,280 and 357,107,231 issued and outstanding, respectively)   $ 359     $ 357  
Paid-in capital in excess of par 3,981,732     3,967,397  
Accumulated overdistributed net investment income (16,907 )   (3,623 )
Accumulated net realized loss (335,671 )   (334,822 )
Net unrealized loss (174,917 )   (193,392 )
Net Assets $ 3,454,596     $ 3,435,917  
       
Net Asset Value Per Share $ 9.62     $ 9.62  
               
 
PROSPECT CAPITAL CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(Unaudited)
 
   Three Months Ended December 31,    Six Months Ended December 31,
  2016   2015   2016   2015
Investment Income              
Interest income:              
Control investments $ 48,281     $ 51,429     $ 94,190     $  103,373  
Affiliate investments     11         896  
Non-control/non-affiliate investments 87,465     88,161     174,125     181,869  
Structured credit securities 39,045     46,902     78,126     91,668  
Total interest income 174,791     186,503     346,441     377,806  
Dividend income:              
Control investments 1,282     13,545     3,522     16,758  
Non-control/non-affiliate investments 97     1     241     3  
Total dividend income 1,379     13,546     3,763     16,761  
Other income:              
Control investments 3,856     3,270     6,796     5,679  
Non-control/non-affiliate investments 3,454     5,872     6,312     9,196  
Total other income 7,310     9,142     13,108     14,875  
Total Investment Income 183,480     209,191     363,312     409,442  
Operating Expenses              
Base management fee 30,886     31,781     61,678     64,735  
Income incentive fee 21,101     25,224     40,831     48,034  
Interest and credit facility expenses 40,848     42,205     82,517     84,162  
Allocation of overhead from Prospect Administration 2,657     2,000     6,190     6,178  
Audit, compliance and tax related fees 1,058     1,192     2,453     3,069  
Directors’ fees 112     94     225     188  
Other general and administrative expenses 2,413     5,802     6,094     10,941  
Total Operating Expenses 99,075     108,298     199,988     217,307  
Net Investment Income 84,405     100,893     163,324     192,135  
Net Realized and Change in Unrealized Gains (Losses) from Investments              
Net realized (losses) gains              
Control investments 178     (8 )   183     (9 )
Affiliate investments         137      
Non-control/non-affiliate investments (260 )   (5,310 )   312     (7,444 )
Net realized (losses) gains (82 )   (5,318 )   632     (7,453 )
Net change in unrealized gains (losses)              
Control investments (11,068 )   (37,104 )   2,298     (77,287 )
Affiliate investments 853     241     (1,273 )   346  
Non-control/non-affiliate investments 26,896     (153,784 )   17,450     (174,981 )
Net change in unrealized gains (losses) 16,681     (190,647 )   18,475     (251,922 )
Net Realized and Change in Unrealized Gains (Losses) from Investments   16,599     (195,965 )   19,107     (259,375 )
Net realized losses on extinguishment of debt (124 )   (48 )   (185 )   (63 )
Net Increase (Decrease) in Net Assets Resulting from Operations $  100,880     $  (95,120 )   $  182,246     $ (67,303 )
Net increase (decrease) in net assets resulting from operations per share $ 0.28     $ (0.27 )   $ 0.51     $ (0.19 )
Dividends declared per share $ (0.25 )   $ (0.25 )   $ (0.50 )   $ (0.50 )
                               
 
PROSPECT CAPITAL CORPORATION AND SUBSIDIARIES
ROLLFORWARD OF NET ASSET VALUE PER SHARE
(in actual dollars)
(Unaudited)
 
   Three Months Ended December 31,    Six Months Ended December 31,
  2016   2015     2016   2015  
Per Share Data                
Net asset value at beginning of period $ 9.60     $  10.17       $   9.62     $  10.31    
Net investment income(1) 0.24     0.28     0.46     0.54    
Net realized losses on investments(1)   (4 ) (0.01 )     (4 ) (0.02 )  
Net change in unrealized appreciation (depreciation) on investments(1)   0.04     (0.54 )   0.05     (0.71 )  
Net realized losses on extinguishment of debt(1)   (4 )   (4 )   (4 )   (4 )
Dividends to shareholders (0.25 )   (0.25 )   (0.50 )   (0.50 )  
Common stock transactions(2) (0.01 )     (4 )   (0.01 )   0.03    
Net asset value at end of period $   9.62     $ 9.65       $ 9.62     $ 9.65    

(1) Per share data amount is based on the weighted average number of common shares outstanding for the year/period presented (except for dividends to shareholders which is based on actual rate per share).

(2) Common stock transactions include the effect of our issuance of common stock in public offerings (net of underwriting and offering costs), shares issued in connection with our dividend reinvestment plan, shares issued to acquire investments and shares repurchased below net asset value pursuant to our Repurchase Program. 

(3) Total return based on market value is based on the change in market price per share between the opening and ending market prices per share in each period and assumes that dividends are reinvested in accordance with our dividend reinvestment plan. Total return based on net asset value is based upon the change in net asset value per share between the opening and ending net asset values per share in each period and assumes that dividends are reinvested in accordance with our dividend reinvestment plan. For periods less than a year, the return is not annualized.

(4) Amount is less than $0.01.

RECONCILIATION OF GAAP NET INVESTMENT INCOME TO DISTRIBUTABLE INCOME

Below is a reconciliation of our NII to distributable income for the three months and six months ended December 31, 2016 (in thousands of dollars, except share and per share data, with all distributable income numbers as current estimates not to be finally determined and announced until after we file our tax returns for our August 31, 2016 and August 31, 2017 tax year):

GAAP Net Investment Income to Distributable Income  Three Months Ended December 31, 2016   Six Months Ended December 31, 2016
GAAP Net Investment Income $ 84,405     $ 163,324  
(Book income in excess of taxable income) taxable income in excess of book income from CLO investments   (8,863 )   (15,372 )
Non-deductible federal excise tax expense (1,100 )   (1,100 )
Taxable gain from pass-through controlled companies (1,119 )   (435 )
Other net additions to distributable income 21     78  
Distributable Income $ 73,344     $ 146,495  
Weighted average shares of common stock outstanding 358,494,783     358,011,031  
Distributable Income per Share $ 0.20     $ 0.41  
               

ABOUT PROSPECT CAPITAL CORPORATION

Prospect Capital Corporation ( www.prospectstreet.com ) is a business development company that focuses on lending to and investing in private businesses. Our investment objective is to generate both current income and long-term capital appreciation through debt and equity investments.

We have elected to be treated as a business development company under the Investment Company Act of 1940 (“1940 Act”). We are required to comply with a series of regulatory requirements under the 1940 Act as well as applicable NASDAQ, federal and state rules and regulations. We have elected to be treated as a regulated investment company under the Internal Revenue Code of 1986. Failure to comply with any of the laws and regulations that apply to us could have an adverse effect on us and our shareholders.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.

For additional information, contact: Grier Eliasek, President and Chief Operating Officer grier@prospectstreet.com Telephone (212) 448-0702

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Coca-Cola's Recent Unusual Options Trends

Updated Category News Views 259

Analyzing Coca-Cola's Recent Options Activity Investors are showing a bearish trend toward Coca-Cola (KO), which is an important indicator for retail traders monitoring investment trends. The recent unusual options activity suggests that these investors may possess insights not yet shared with the public. Thus, individual traders should be particularly attentive to these...

Continue Reading
Sustainable Palm Oil Market Growth Driven by AI Insights

Updated Category News Views 136

Exploring the Growth of the Sustainable Palm Oil Market The sustainable palm oil market is currently on the rise, fueled by a growing demand for trans-fat-free products and innovations in eco-friendly farming practices. This growth is expected to hit around USD 2.75 billion by 2028, reflecting a solid compound annual growth rate (CAGR) of about 5.24% in the coming years....

Continue Reading
Grilling Safety Tips from Ferrellgas This Labor Day

Updated Category News Views 82

Grilling Safety Tips from Ferrellgas This Labor Day As we gear up for one of the biggest grilling holidays of the year, it's essential to keep safety in mind while savoring delicious meals with family and friends. Ferrellgas Partners, L.P. is taking this opportunity to remind customers about the significance of safe grilling practices this Labor Day. This holiday not only...

Continue Reading
Solstice Gold Secures Funding Through Successful Placement Deal

Updated Category News Views 127

Solstice Gold Completes Successful Private Placement Financing Solstice Gold Corp. (“Solstice”, “we”, “our”, or the “Company”) is thrilled to announce the successful closing of its private placement financing. This significant financial milestone comes with gross proceeds of approximately $150,000 from the issuance of 6,600,000 shares. This private...

Continue Reading
Avanos Medical Introduces Innovative CORGRIP SR System

Updated Category News Views 32

Avanos Medical Launches New CORGRIP SR Advancement to reduce dislodgement in feeding tube retention systems Avanos Medical, Inc. (NYSE: AVNS) recently announced an exciting development in its Enteral Feeding portfolio with the launch of the CORGRIP SR Nasogastric/Nasointestinal Tube Retention System. This innovative design aims to provide enhanced support and security for...

Continue Reading